CXCL12 and glioma: We previously showed using an agent based model that heterogeneous populations of glioma cells are exquisitely sensitive to small changes in CXCR4 and CXCL12 co-expressing cells, leading to enhanced flow response via this autologous chemotaxis mechanism7.